Active Not Recruiting PHASE1 INTERVENTIONAL 2-arm NCT06933459

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

An Open Label, Randomized, Single Dose, 2-sequence, 2-period, Cross-over Phase 1 Study to Evaluate the Safety and Pharmacokinetics of AJU-C714 Compared to C714R in Healthy Adult Volunteers

Sponsor: AJU Pharm Co., Ltd.

Conditions Dyslipidemia

Interventions Reference Drug Test Drug

Updated 3 times since 2025 Last updated: Jun 9, 2025 Started: May 24, 2025 Primary completion: Jun 11, 2025 Completion: Jun 24, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Dyslipidemia and is currently ongoing. AJU Pharm Co., Ltd. leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2025 — Present [monthly]

Active Not Recruiting PHASE1
Jul 2025 — Sep 2025 [monthly]

Active Not Recruiting PHASE1

Status: Not Yet Recruiting → Active Not Recruiting
May 2025 — Jul 2025 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AJU Pharm Co., Ltd.

Data source: AJU Pharm Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea